Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 32 (4) , 490-505.e10
Abstract
No abstract availableKeywords
Funding Information
- NCI (1R01CA178394, 5R35CA197583, R01CA217092)
- Sidney Kimmel Foundation for Cancer Research
- Gabrielle's Angels Foundation for Cancer Research
- Alexandrine and Alexander L. Sinsheimer Foundation
- Pershing Square Sohn Cancer Research Alliance
- William Lawrence and Blanche Hughes Foundation
- Leukemia and Lymphoma Scholar
- NIH (1S10OD016305, P30 CA013330)
- Gottesman Institute for Stem Cell Research and Regenerative Medicine (no. C029154)
This publication has 55 references indexed in Scilit:
- Direct and selective small-molecule activation of proapoptotic BAXNature Chemical Biology, 2012
- BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial poreTrends in Biochemical Sciences, 2011
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the MitochondriaMolecular Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Apoptosis and oncogenesis: give and take in the BCL-2 familyCurrent Opinion in Genetics & Development, 2011
- BH3-Triggered Structural Reorganization Drives the Activation of Proapoptotic BAXMolecular Cell, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial ApoptosisMolecular Cell, 2009
- BAX activation is initiated at a novel interaction siteNature, 2008
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006